BOSTON, Dec. 4, 2023 /PRNewswire/ -- Sensorium Therapeutics (Sensorium), a biotechnology company leveraging machine learning, medicinal chemistry and neuroscience to develop nature-inspired psychoactive medicines for mental health, today announced its incoming Chief Executive Officer. Sensorium welcomed Alexandra (Sandra) Glucksmann, Ph.D., as CEO and President, as former CEO and Co-founder, Dick Simon, transitions to an advisory role while continuing to serve on the Board of Directors.
CU Anschutz
Anschutz Health Sciences Building
1890 N Revere Ct
Suite 6202
Aurora, CO 80045